Emergency Information Take Over
Friday, November 22, 2013
Francis S. Collins, MD, PhD, Director, National Institutes of Health
Accelerating Innovation and Discovery in Medicine (ACCEL-Med), a major initiative of the University Of Maryland School Of Medicine was launched on November 22, 2013. ACCEL-Med will increase the pace and scope of clinical and basic sciences research and will dramatically impact and improve human health and wellbeing. The initiative kicked off with a full-day symposium, the SOM Festival of Science. Francis Collins, MD, PhD, Director of the National Institutes of Health, delivered the inaugural keynote address.
“Our nation has really benefited from being at the forefront of science, technology and innovation,” said Dr. Collins, who spoke about the current environment for biomedical research, including the need for advancing discovery through technology and translational sciences, the importance of continuous innovation and the economic benefits of medical research. Speaking to an overflow crowd of physician-scientists and researchers, Dr. Collins added: “Do not feel shy about justifying why what you do is a really valuable investment for the American public.”
The Festival featured a series of 12 faculty presentations showcasing the groundbreaking basic, translational and clinical research being conducted at the University Maryland School of Medicine. “This ACCEL-Med initiative and today’s Festival of Science demonstrate that we are not just doing business as usual,” said E. Albert E. Reece, MD, PhD, MBA, Vice President for Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine. “We are willing to evaluate and challenge our research portfolio as we boldly embrace the future.”
The first Festival of Science highlighted research conducted by the Institute for Genome Sciences, the Department of Pharmacology, and the Department of Surgery. Topics included gene sequencing, neuropharmacology, advances in transplant science, and the use of stem cells to treat serious heart problems in children. View the complete agenda.
A cornerstone of the ACCEL-Med Initiative is an external Scientific Advisory Council (SAC), which consists of five internationally acclaimed biomedical researchers and physician-scientists, who provide critical advice on SOM’s research, programs and plans, as well as guidance and support for junior faculty presenters.
“We are delighted to welcome Dr. Collins to our campus and that a dais of preeminent scientists has agreed to be a part of the Scientific Advisory Council for the ACCEL-Med Initiative,” said Dean Reece.
Rita Colwell, PhD
Distinguished Professor at the University of Maryland College Park and the Johns Hopkins University Bloomberg School of Public Health | Former Director, National Science Foundation | 2006 National Medal of Science recipient | Member, Institute of Medicine of the National Academy of Sciences
Carol Greider, PhD
Daniel Nathans Professor and Director, Department of Molecular Biology and Genetics, Institute of Basic Biomedical Sciences, Johns Hopkins University School of Medicine | Awarded 2009 Nobel Prize for Physiology or Medicine | Member, Institute of Medicine of the National Academy of Sciences
Philip Needleman, PhD
Former President/CEO, St. Louis Science Center | Former President, Searle R&D | Member, Institute of Medicine of the National Academy of Sciences
Ralph Snyderman, MD (Council Chair)
Chancellor Emeritus, Duke University & James B. Duke Professor of Medicine | Former President & CEO, Duke University Health System | Former Chair, Association of American Medical Colleges | Member, Institute of Medicine of the National Academy of Sciences
Elias Zerhouni, MD
President of Global R&D, Sanofi Pharmaceutical | Former Director, National Institutes of Health | Member, Institute of Medicine of the National Academy of Sciences
Before the formal opening of the Festival, Dr. Collins officially dedicated the Center for Innovative Biomedical Resources (CIBR), on the 7th floor of the Bressler Research Building. CIBR is the new home for many of the School of Medicine’s biomedical core facilities, which have been consolidated into 30,000 square feet of renovated space – a $7.3 million project funded by The American Recovery and Reinvestment Act.
The CIBR facilities serve as a center of excellence for state-of-the-art technologies, equipment, and expertise that supports biomedical research, clinical practice and health care in the state of Maryland and the region. The new facilities give faculty greater access to sophisticated instrumentation as well as highly-trained technical staff who can offer support to faculty on experimental design, data analysis and interpretation, and provide training for graduate and medical students, postdoctoral fellows, and faculty.
Dean Reece also announced a series of major initiatives– including new technology, new collaborations and new translational research programs -- that will further strengthen the School’s position as one of the fastest growing biomedical research enterprises in the nation.
Established in 1807, the University of Maryland School of Medicine was the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.
University of Maryland School of Medicine
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations